Vanguard Group Inc Cullinan Oncology, Inc. Transaction History

Vanguard Group Inc

$5.57 Trillion
Q4 2024

A detailed history of Vanguard Group Inc transactions in Cullinan Oncology, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,936,227 shares of CGEM stock, worth $26.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,936,227

Previous 2,998,714 2.08%

Holding current value

$26.5 Million

Previous $50.2 Million 28.76%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$10.77 - $17.6 $672,984 - $1.1 Million	-62,487 Reduced 2.08%	2,936,227 $35.8 Million
Q3 2024 Nov 13, 2024	BUY	$16.03 - $20.86 $2.04 Million - $2.66 Million	127,339 Added 4.43%	2,998,714 $50.2 Million
Q2 2024 Aug 13, 2024	BUY	$15.63 - $29.35 $17.1 Million - $32.2 Million	1,097,030 Added 61.83%	2,871,375 $50.1 Million
Q1 2024 May 10, 2024	BUY	$10.17 - $19.02 $29,513 - $55,196	2,902 Added 0.16%	1,774,345 $30.2 Million
Q4 2023 Feb 14, 2024	BUY	$7.89 - $10.23 $654,159 - $848,169	82,910 Added 4.91%	1,771,443 $18.1 Million
Q3 2023 Nov 14, 2023	SELL	$9.05 - $11.72 $3.07 Million - $3.97 Million	-338,873 Reduced 16.71%	1,688,533 $15.3 Million
Q2 2023 Aug 14, 2023	SELL	$8.8 - $13.4 $4.64 Million - $7.07 Million	-527,582 Reduced 20.65%	2,027,406 $21.8 Million
Q1 2023 May 15, 2023	SELL	$10.2 - $11.91 $2.63 Million - $3.07 Million	-257,977 Reduced 9.17%	2,554,988 $26.1 Million
Q4 2022 Feb 10, 2023	BUY	$9.72 - $13.62 $466,171 - $653,215	47,960 Added 1.73%	2,812,965 $29.7 Million
Q3 2022 Nov 14, 2022	BUY	$11.82 - $15.42 $230,324 - $300,474	19,486 Added 0.71%	2,765,005 $35.4 Million
Q2 2022 Aug 12, 2022	BUY	$7.31 - $13.55 $2.88 Million - $5.33 Million	393,394 Added 16.73%	2,745,519 $35.2 Million
Q1 2022 May 13, 2022	SELL	$10.47 - $16.75 $153,731 - $245,940	-14,683 Reduced 0.62%	2,352,125 $24.6 Million
Q4 2021 Feb 14, 2022	BUY	$15.36 - $25.0 $1.31 Million - $2.13 Million	85,357 Added 3.74%	2,366,808 $36.5 Million
Q3 2021 Nov 12, 2021	BUY	$22.56 - $29.68 $25.4 Million - $33.4 Million	1,125,686 Added 97.4%	2,281,451 $51.5 Million
Q2 2021 Aug 13, 2021	BUY	$24.96 - $41.25 $28.8 Million - $47.7 Million	1,155,765 New	1,155,765 $29.8 Million

Others Institutions Holding CGEM

# of Institutions

153

Shares Held

67.1M

Call Options Held

41.1K

Put Options Held

112K

View Full List

About Cullinan Oncology, Inc.

Ticker CGEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,612,200
Market Cap $412M
Description
Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...

More about CGEM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Cullinan Oncology, Inc. Transaction History